- Home
- Products
- Customized FluoroAb™
- SLC44A4
- Anti-SLC44A4 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester
Anti-SLC44A4 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12781)
- TARGET
- ANTIBODY
- DYE
- Name
- SLC44A4
- Overview
- Human Anti-SLC44A4 lgG1 Antibody (Clone 3)
- Species Reactivity
- Human
- Name
- iFluor® 532 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 537/560
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS12781. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-476 | Anti-SLC44A4-VC-MMAE ADC-2 | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-449 | Anti-SLC44A4-Mc-MMAE ADC | Mc (maleimidocaproyl) | MMAE (Monomethyl auristatin E) |
| ADC-W-447 | Anti-SLC44A4-VC-MMAE ADC-1 | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-448 | Anti-SLC44A4-VC-Mc-MMAE ADC | VC-Mc- (valine-citrulline-maleimidocaproyl) | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-NGcGM3 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7777)
- Anti-EGFR MAb (Clone 13)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9719)
- Radretumab-Cy3 (CAT#: ADC-FL-1508)
- Anti-LTA MAb (Clone 14)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13698)
- Anti-CD33 MAb (Clone 18)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10255)
- Anti-HCMV MAb (Clone 3)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS3132)
- Siplizumab-Fluoresein (CAT#: ADC-FL-412)
- Anti-CSF1R MAb (Clone 4)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7797)
- Anti-CD2 MAb (Clone 8)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2643)
- Anti-VEGFA MAb (Clone 15)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9244)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
